Top 10 Low Price Stocks To Invest In 2019

tags:EDGE,APOP,CE,BMTC,CPSS,HTHIF,LKQ,VYGR,PBT,HPQ,

Private equity shops thought they saw a sure-fire way to make a buck: build dozens of new power plants fueled by cheap Appalachian natural gas to replace old coal-fired units.

It hasn’t quite turned out that way, at least not yet. Many of the new plants built in the last few years aren’t kicking off as much cash as the buyout firms had expected, according to bankers. There’s not enough demand to support the huge amount of additional new capacity, driving down electricity prices. And with President Donald Trump as a booster, shutdowns of coal haven’t come as quickly as anticipated while states are acting to keep nuclear plants open.

None of the new plants appear in danger of default, analysts said. But several plant owners are now using most of the extra cash they are generating to pay down debt.

Moreover, low prices and the results of a closely watched regional power-price auction scheduled for Wednesday could force many of the gas-fired plants built in the last five years to refinance their debt. At least one new U.S. plant, owned in part by an arm of private equity firm Ares Management LP, recently did so.

Top 10 Low Price Stocks To Invest In 2019: Edge Therapeutics, Inc.(EDGE)

Advisors' Opinion:

• [By Ethan Ryder]

  Edge Therapeutics Inc (NASDAQ:EDGE) shares were down 6.8% on Tuesday . The stock traded as low as $1.07 and last traded at $1.10. Approximately 1,087,000 shares changed hands during mid-day trading, a decline of 7% from the average daily volume of 1,164,140 shares. The stock had previously closed at $1.18.

• [By Logan Wallace]

  Media headlines about Edge Therapeutics (NASDAQ:EDGE) have been trending somewhat positive on Sunday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Edge Therapeutics earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 42.6657723226264 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

• [By Paul Ausick]

  Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 14.5% Thursday to post a new 52-week low of $1.12. Shares closed at $1.31 on Wednesday and the stock’s 52-week high is $17.77. Volume was nearly 20 times the daily average of around 700,000 shares. The company on Wednesday ended a trial after reporting poor results and shares fell more than 90% on the news.

• [By Paul Ausick]

  Edge Therapeutics Inc. (NASDAQ: EDGE) dropped 92.6% Wednesday to post a new 52-week low of $1.15. Shares closed at $15.59 on Tuesday and the stock’s 52-week high is $17.77. Volume was nearly 300 times the daily average of around 160,000 shares. The company ended a trial after reporting poor results.

Top 10 Low Price Stocks To Invest In 2019: Cellect Biotechnology Ltd. (APOP)

Advisors' Opinion:

• [By Lisa Levin] Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading. Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading. Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading. Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading. MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading. Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan. Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading. MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading. Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results. Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading. Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings. Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

   

• [By Max Byerly]

  Get a free copy of the Zacks research report on CELLECT BIOTECH/S (APOP)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Shane Hupp]

  Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

• [By Stephan Byrd]

  Media stories about CELLECT BIOTECH/S (NASDAQ:APOP) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CELLECT BIOTECH/S earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3583768207142 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

• [By Shane Hupp]

  CELLECT BIOTECH/S (NASDAQ:APOP)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Tuesday. They presently have a $14.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 91.00% from the stock’s previous close.

Top 10 Low Price Stocks To Invest In 2019: Celanese Corporation(CE)

Advisors' Opinion:

• [By Stephan Byrd]

  Stephens Inc. AR lowered its holdings in shares of Celanese Co. (NYSE:CE) by 9.7% in the 2nd quarter, Holdings Channel reports. The fund owned 4,113 shares of the basic materials company’s stock after selling 441 shares during the period. Stephens Inc. AR’s holdings in Celanese were worth $457,000 at the end of the most recent quarter.

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Celanese (CE)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Ethan Ryder]

  ILLEGAL ACTIVITY WARNING: “Parallel Advisors LLC Has $117,000 Stake in Celanese Co. (CE)” was reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/4159512/parallel-advisors-llc-has-117000-stake-in-celanese-co-ce.html.

• [By Max Byerly]

  Loomis Sayles & Co. L P purchased a new position in Celanese Co. (NYSE:CE) during the 1st quarter, HoldingsChannel reports. The firm purchased 101,256 shares of the basic materials company’s stock, valued at approximately $10,147,000.

• [By Ethan Ryder]

  Jennison Associates LLC trimmed its stake in shares of Celanese Co. (NYSE:CE) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 527,082 shares of the basic materials company’s stock after selling 3,006 shares during the period. Jennison Associates LLC’s holdings in Celanese were worth $58,538,000 as of its most recent SEC filing.

Top 10 Low Price Stocks To Invest In 2019: Bryn Mawr Bank Corporation(BMTC)

Advisors' Opinion:

• [By Max Byerly]

  Get a free copy of the Zacks research report on Bryn Mawr Bank (BMTC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Joseph Griffin]

  Bryn Mawr Bank (NASDAQ:BMTC) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Saturday.

• [By Joseph Griffin]

  Bryn Mawr Bank Corp. (NASDAQ:BMTC) has been assigned a consensus rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $53.67.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Bryn Mawr Bank (BMTC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Get a free copy of the Zacks research report on Bryn Mawr Bank (BMTC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Logan Wallace]

  Shares of Bryn Mawr Bank Corp. (NASDAQ:BMTC) have received a consensus rating of “Hold” from the six research firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $53.67.

Top 10 Low Price Stocks To Invest In 2019: Consumer Portfolio Services Inc.(CPSS)

Advisors' Opinion:

• [By Stephan Byrd]

  ValuEngine upgraded shares of Consumer Portfolio Services (NASDAQ:CPSS) from a sell rating to a hold rating in a report issued on Tuesday.

  Other research analysts also recently issued research reports about the company. Jefferies Financial Group reaffirmed a buy rating and issued a $5.00 price target on shares of Consumer Portfolio Services in a research note on Thursday, July 26th. Zacks Investment Research upgraded Consumer Portfolio Services from a sell rating to a hold rating in a research report on Monday, August 27th. Finally, JMP Securities upgraded Consumer Portfolio Services from a market perform rating to an outperform rating and set a $6.00 target price on the stock in a research report on Friday, June 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $5.08.

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Consumer Portfolio Services (CPSS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Invest In 2019: Hitachi Ltd (HTHIF)

Advisors' Opinion:

• [By ]

  Some of the larger companies that have begun incorporating blockchain into their industries include:

  Overstock.com (OSTK) , once a retail company, has become one of the biggest blockchain options on the stock market. The company has developed tZERO, a cryptocurrency and blockchain-based registry that complies with the regulations of the U.S. Securities & Exchange Commission. IBM (IBM) has developed blockchain technology that they are using with a large variety of partners in a large variety of industries. One example is their partnership with food retailers, most notably Walmart, to help quickly, efficiently, and securely track the supply chain to help ensure ideal food safety. They have also partnered with Maersk to work on a blockchain platform for global trade. Hitachi (HTHIF) , the Japanese conglomerate that has worked on social infrastructure and IT systems, among other industries, has begun dabbling in blockchain. It has released reports about how it believes the technology can positively impact the financial sector, and how it could potentially be used to create new services for businesses.

  There are also ETFs that one can invest in that hold a number of stocks related to blockchain. For example, the Reality Shares Nasdaq NextGen Economy ETF (BLCN) holds stocks in all of the examples above, as well as Intel (INTC) and Cisco Systems (CSCO) .

• [By ]

  The vast dealer network, built up over the more than 90 years that Caterpillar has been in operation, is the key competitive advantage that the company possesses. While Caterpillar's products are renowned for quality and low downtime, it is the availability of the support service on an international level in tandem with a reputation for product quality is what gives Caterpillar its edge, and has given it pole position among the world's construction machinery manufacturers in 2017 based on construction equipment sales, outranking Komatsu Ltd. (OTCPK:KMTUF) (OTCPK:KMTUY), Hitachi Ltd. (OTCPK:HTHIF) (OTCPK:HTHIY), Volvo (OTCPK:VOLVF) (OTCPK:VOLVY), the privately-held Liebherr group, the Chinese government-owned XCMG Group, the Doosan Infracore subsidiary of the Doosan Group conglomerate, Sany (OTCPK:SNYYF) (OTC:SNYYY), and John Deere & Co.

Top 10 Low Price Stocks To Invest In 2019: LKQ Corporation(LKQ)

Advisors' Opinion:

• [By Dan Caplinger]

  LKQ (NASDAQ:LKQ) has found itself an extremely profitable niche in the auto parts and accessories business. By concentrating largely on the specialty and alternative market, LKQ aims to capture higher-margin business that many other parts manufacturers choose not to pursue. That's generally been a winning formula for the company over the long run.

• [By Chris Lange]

  The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was LKQ Corp. (NASDAQ: LKQ) which traded down about 19% at $30.43. The stock's 52-week range is $29.60 to $43.86. Volume was 15 million compared to the daily average volume of 1.8 million.

• [By Stephan Byrd]

  LKQ Co. (NASDAQ:LKQ) was the target of some unusual options trading activity on Wednesday. Traders purchased 2,843 put options on the stock. This represents an increase of 2,990% compared to the average daily volume of 92 put options.

Top 10 Low Price Stocks To Invest In 2019: Voyager Therapeutics, Inc.(VYGR)

Advisors' Opinion:

• [By Trey Thoelcke]

  Voyager Therapeutics Inc. (NASDAQ: VYGR) also saw a director at the buy window last week. At an average of $18.31 apiece, the 3,000 shares reportedly acquired cost that director less than $55,000. Here too, a disappointing earnings report had shares down, offering an entry point. The stock was last seen up more than 12% from the purchase price, so seemingly a well-timed buy.

• [By Chris Lange]

  Voyager Therapeutics Inc. (NASDAQ: VYGR) will be presenting at the American Society of Gene and Cell Therapy annual meeting taking place May 16 to 19, 2018, in Chicago. The firm will be releasing data from its lead clinical program for Parkinson's disease, its preclinical programs targeting a monogenic form of amyotrophic lateral sclerosis (ALS) called SOD1, Huntington's disease and Friedreich's ataxia, and its gene therapy vector platform including novel adeno-associated virus capsid optimization efforts and manufacturing capabilities.

• [By Logan Wallace]

  These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

  Get Voyager Therapeutics alerts: Consensus Target Price Watch for Voyager Therapeutics, Inc. (NASDAQ:VYGR) (baycityobserver.com) Checking the Levels on Shares of Voyager Therapeutics, Inc. (NasdaqGS:VYGR) as PI Hits 0.73287 (baycityobserver.com) Are Institutions Giving Voyager Therapeutics, Inc. (NASDAQ:VYGR) a Vote of Confidence? (cantoncaller.com) 7 Biotech Stocks Insiders Are Loading Up On (msn.com) James A. Geraghty Purchases 3,000 Shares of Voyager Therapeutics Inc (VYGR) Stock (americanbankingnews.com)

  Several research analysts have recently issued reports on the company. Canaccord Genuity set a $35.00 price target on Voyager Therapeutics and gave the stock a “buy” rating in a research note on Wednesday, June 6th. BTIG Research reissued a “buy” rating and issued a $32.00 price target on shares of Voyager Therapeutics in a research note on Thursday, June 7th. BidaskClub raised Voyager Therapeutics from a “hold” rating to a “buy” rating in a research note on Wednesday, June 6th. Chardan Capital reissued a “hold” rating and issued a $30.00 price target on shares of Voyager Therapeutics in a research note on Thursday, June 21st. Finally, HC Wainwright initiated coverage on Voyager Therapeutics in a research note on Monday, June 4th. They issued a “buy” rating and a $30.00 price target for the company. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Voyager Therapeutics currently has a consensus rating of “Buy” and an average target price of $32.18.

• [By Max Byerly]

  Voyager Therapeutics (NASDAQ:VYGR)’s share price was down 3.3% during trading on Tuesday . The company traded as low as $20.45 and last traded at $21.04. Approximately 9,445 shares traded hands during trading, a decline of 98% from the average daily volume of 399,751 shares. The stock had previously closed at $20.37.

• [By Lisa Levin] Gainers The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results. MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast. Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39. Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results. ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings. Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million. Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results. Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results. VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71. Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results. Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results. Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results. Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739. Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
• [By Max Byerly]

  Get a free copy of the Zacks research report on Voyager Therapeutics (VYGR)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Low Price Stocks To Invest In 2019: Permian Basin Royalty Trust(PBT)

Advisors' Opinion:

• [By Max Byerly]

  Primalbase Token (CURRENCY:PBT) traded down 2.5% against the US dollar during the 1 day period ending at 23:00 PM Eastern on May 26th. Primalbase Token has a total market cap of $1.90 million and $282,320.00 worth of Primalbase Token was traded on exchanges in the last day. One Primalbase Token token can now be bought for about $1,516.30 or 0.20760100 BTC on popular exchanges including Tidex and Waves Decentralized Exchange. During the last week, Primalbase Token has traded down 30.5% against the US dollar.

• [By Shane Hupp]

  Primalbase Token (CURRENCY:PBT) traded up 15% against the US dollar during the one day period ending at 21:00 PM ET on October 5th. One Primalbase Token token can now be bought for about $5,129.81 or 0.77606090 BTC on popular exchanges including Tidex and Waves Decentralized Exchange. Primalbase Token has a total market capitalization of $6.41 million and $1,838.00 worth of Primalbase Token was traded on exchanges in the last 24 hours. During the last seven days, Primalbase Token has traded up 42.2% against the US dollar.

• [By Joseph Griffin]

  Primalbase Token (CURRENCY:PBT) traded up 8.5% against the dollar during the twenty-four hour period ending at 17:00 PM E.T. on September 4th. Primalbase Token has a market capitalization of $5.13 million and $2,945.00 worth of Primalbase Token was traded on exchanges in the last 24 hours. One Primalbase Token token can now be bought for about $4,100.42 or 0.55692938 BTC on major cryptocurrency exchanges including Waves Decentralized Exchange and Tidex. Over the last seven days, Primalbase Token has traded up 6.6% against the dollar.

• [By Shane Hupp]

  Primalbase Token (CURRENCY:PBT) traded 27.1% higher against the U.S. dollar during the one day period ending at 22:00 PM Eastern on February 18th. Primalbase Token has a market cap of $3.65 million and $12,179.00 worth of Primalbase Token was traded on exchanges in the last 24 hours. In the last seven days, Primalbase Token has traded 35.9% higher against the U.S. dollar. One Primalbase Token token can now be purchased for $2,917.24 or 0.74484977 BTC on cryptocurrency exchanges including Tidex and Waves Decentralized Exchange.

Top 10 Low Price Stocks To Invest In 2019: HP Inc.(HPQ)

Advisors' Opinion:

• [By ]

  HP (HPQ) : "There's a hatred of technology right now, but this one is terrific and I say buy."

  Advanced Micro Devices (AMD) : "Under $10, you want to pick up some AMD."

• [By Matthew Cochrane]

  In late 2015, Hewlett-Packard split into two distinct companies: HP Inc. (NYSE:HPQ) and Hewlett-Packard Enterprise Co. (NYSE:HPE). Those who advocated for the split can take a bow as, since the break-up, both companies have been allowed to focus on their respective expertise and have handily outperformed the S&P 500 index. HP Inc's performance has been especially surprising, as this was supposed to be the company that was focused on a staid printing market and a declining personal computer (PC) environment. Yet its shares have not only outgained the market, but its underlying business continues to grow as it gains market share and shows profitable growth.

• [By ]

  Between 2011 and 2014, HP (NYSE: HPQ) downsized its labor pool by 85,000 people. Those layoffs reflected decreased demand for the company's PCs and printers. Indeed, annual sales fell markedly over that time frame -- and the stock tumbled. 

• [By Ethan Ryder]

  Get a free copy of the Zacks research report on HP (HPQ)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Leo Sun]

  HP (NYSE:HPQ) recently partnered with Guangdong 3D Printing Collaborative Innovation Platform to open a new 3D printing center in China. The Lanwan Intelligence-HP Multi-Jet Fusion Technology Mass Manufacturing Center, located in the town of Dali, will host HP's largest ever deployment of production-grade 3D printers in Asia.

• [By Leo Sun]

  HP (NYSE:HPQ) is the biggest PC maker in the world. Many have claimed that smartphones and tablets would kill the PC market, yet IDC recently reported that PC sales rose nearly 3% annually during the third quarter -- marking the strongest growth in six years.